Novo Nordisk
Develops biological medicines and delivery systems for patients with diabetes and other serious chronic diseases
Highlights
- New on EvolcAdded 2026-10-30
About Novo Nordisk
Novo Nordisk is a global healthcare company that discovers and develops biological medicines, delivery systems and digital health solutions. Its focus includes diabetes, obesity, rare blood diseases and rare endocrine diseases.
The company makes medicines accessible to patients worldwide and also works with universities and biotechnology companies on drug discovery. Novo Nordisk Limited is the UK legal entity; the provided registry facts place its headquarters in Gatwick and its founding in 1973.
Product: Biological medicines, delivery systems and digital health solutions for chronic and rare diseases.
Jobs at Novo Nordisk
More biotech & pharma companies
Novogaia
AI-driven drug discovery company developing medicines from fungi for unmet medical needsNovogene (UK) Company
Sequencing and multiomics research services for academic, clinical, biotech and biopharma teamsNovumgen
Develops and licenses medicines and finished formulations for pharma partners in oncology, immunology and rare diseasesNew on EvolcNRG Therapeutics
Develops oral medicines for ALS, Parkinson’s and other neurodegenerative diseasesNew on EvolcNuclearmedix
Develops radiopharmaceuticals for cancer diagnosis and treatment, with an initial focus on neuroendocrine tumour imagingYoung companyNew on EvolcNuclera
Automated protein screening instrument and antibody triage services for protein scientists and biopharma labs
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Azure
- Fastly
- OneTrust